Epithelial Cell Adhesion Molecules (EpCAMs) Promote Drug Resistance in Breast Cancer Cells by Enhancing Tight Junctions
10.13865/j.cnki.cjbmb.2022.05.1035
- Author:
Ya-Nan NIU
1
;
Yu GAO
1
;
Yi-Fan HE
1
;
Ke-Min LI
1
;
Xuan-Ping ZHANG
1
;
Rui-Zan SHI
1
;
Rui-Han LI
2
;
Wen-Long ZHANG
2
Author Information
1. Department of Pharmacology, School of Basic Medicine, Shanxi Medical University
2. Department of First Clinical Medicine, Shanxi Medical University
- Publication Type:Journal Article
- Keywords:
breast cancer;
claudin 1;
drug resistance;
epithelial cell adhesion molecule(EpCAM);
intercellular tight junctions
- From:
Chinese Journal of Biochemistry and Molecular Biology
2022;38(6):809-815
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer is a malignant tumor with high mortality, and multidrug resistance (MDR) mediated by ABCG2 (ATP-Binding cassette G2) is an important cause of chemotherapy failure. It is an urgent problem to explore the mechanism of ABCG2-mediated drug resistance and its key molecules. Epithelial cell adhesion molecule (EpCAM) is involved in multiple tumor drug resistance and is closely related to breast cancer MDR. However, its role in ABCG2-mediated breast cancer drug resistance has not been clarified. The purpose of this study was to explore the regulation of EpCAM on ABCG2-mediated MDR in breast cancer cells and its mechanism. CCK8 cytotoxicity assays confirmed that the drug resistance of MCF-7/MX cell line to mitoxantrone (MX) was significantly increased compared with MCF-7 drug-sensitive strain of human breast cancer. Western blotting results showed that ABCG2 was highly expressed and EpCAM was up-regulated in MCF-7/MX cells compared with MCF-7. SiRNA knockdown of EpCAM in MCF-7/MX cells down-regulated ABCG2 expression and restored sensitivity to MX. Cell morphology was observed under an inverted microscope, and it was found that knocking down EpCAM reduced cell-cell connections between MCF-7/MX cells. The co-localization of EpCAM and claudin 1 in MCF-7/MX cells was observed by immunofluorescence. Furthermore, Western blotting results showed that EpCAM knockdown reduced claudin 1 expression in MCF-7/MX cells. In conclusion, EpCAM may promote ABCG2-mediated mMDR in breast cancers by enhancing intercellular tight junctions through interaction with claudin 1.
